The global conjunctivitis therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Conjunctivitis is a kind of eye condition, which is commonly known as pink eye. The market is projected to show substantial growth due to the high number of people suffering from allergic conjunctivitis and the easier availability of the treatment across the globe. Although the disease is very common, treatment for it is easily available globally. Generally, conjunctivitis is self diagnosable and there is the minimum need of undergoing any diagnostic test for it.
Emerging economies such as India also witnessed a high prevalence of the disease. According to an article published by the journal Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. Hence, due to the high prevalence of the disease, the market is projected to have a steady growth during the forecast period.
Some key players operating in the market include Novartis International AG, Bausch & Lomb Incorporated, Allergan, NicOx S.A., Alembic Pharmaceuticals, among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.
Market Coverage
Competitive Landscape: Novartis International AG, Bausch & Lomb Incorporated, Allergan, NicOx S.A., Alembic Pharmaceuticals, among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Conjunctivitis Therapeutics Market by Segment
By Disease Type
• Allergic Conjunctivitis
• Bacterial Conjunctivitis
• Viral Conjunctivitis
By Formulation Type
• Ointment
• Drops
• Drugs
Global Conjunctivitis Therapeutics Market by Region
North America
Europe
Asia-Pacific
Rest of the World